This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: The Innovations of Charles M. Habecker
Introduction
Charles M. Habecker is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of ophthalmology through his innovative work on antiglaucoma agents. His research has led to advancements in the treatment of elevated intraocular pressure and glaucoma.
Latest Patents
Habecker holds a patent for "Thiophene sulfonamide antiglaucoma agents." This patent describes aryl (or aralkyl)-sulfonylthiophene-2-sulfonamides that contain a basic functional group as a substituent. These compounds have been shown to be efficacious in treating elevated intraocular pressure and glaucoma following topical ocular administration. He has 1 patent to his name.
Career Highlights
Charles M. Habecker is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative solutions for eye care, particularly in the area of glaucoma treatment.
Collaborations
Habecker has collaborated with esteemed colleagues such as John J. Baldwin and Samuel L. Graham. These partnerships have contributed to the advancement of research and development in the pharmaceutical field.
Conclusion
Charles M. Habecker's contributions to the field of ophthalmology through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to impact the treatment of glaucoma and elevated intraocular pressure.